[1] 中华人民共和国国家卫生健康委员会.卫生部关于印发《医务人员艾滋病病毒职业暴露防护工作指导原则(试行)》的通知[EB/OL].(2004-04-06)[2020-09-21].http://www.nhc.gov.cn/wjw/gfxwj/201304/588fcab93194457cb2cdf3f150b3faac.shtml. [2] 中国疾病预防控制中心性病艾滋病预防控制中心.《艾滋病病毒暴露后预防技术指南(试用)》[EB/OL].(2020-11-16)[2020-11-18].http://ncaids.chinacdc.cn/tzgggd/202011/t20201116_222780.html. [3] 中国疾病预防控制中心.中华医学会感染病学分会艾滋病丙型肝炎学组.中国艾滋病诊疗指南(2018版)[J].新发传染病电子杂志,2019, 4(2):65-84. [4] WHO.Global HIV,Hepatitis and STIs Programme[EB/OL].(2020-11)[2020-11-16].https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/data-use/hiv-data-and-statistics [5] JOYCE M P,KUHAR D,BROOKS J T.Notes from the field:occupationally acquired HIV infection among health care workers-United States,1985-2013[J].MMWR Morb Mortal Wkly Rep,2015,63(53):1245-1246. [6] 疾病预防控制局.解读《职业暴露感染艾滋病病毒处理程序规定》[EB/OL].(2015-07-23)[2020-09-21].http://www.nhc.gov.cn/jkj/s3586/201507/22321c7206ea4696aadb1695fd46d28c.shtml. [7] MAATEN G,NYIRENDA M,BEADSWORTH M,et al.Post exposure prophylaxis of HIV transmission after occupational injuries in queen elizabeth central hospital,blantyre,malawi,2003-2008[J].Malawi Med J,2010,22(1):15-19. [8] 傅亮. 艾滋病临床护理实践指南的构建研究[D].上海:复旦大学,2014. [9] 李韩平,李宏,杨坤,等.河南部分艾滋病病人ART的临床效果以及基因型耐药性分析[J].中华微生物学和免疫学杂志,2005,25(3):194-198. [10] CHEN J,ZHANG M,SHANG M,et al.Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from henan province in China[J].BMC Infect Dis,2018,18(1):571. [11] TETTEH R A,NARTEY E T,LARTEY M,et al.Adverse events and adherence to HIV post-exposure prophylaxis:A cohort study at the Korle-Bu Teaching Hospital in Accra,Ghana[J].BMC Public Health,2015,15:573. [12] 郭秀花. 医学现场调查技术与统计分析[M].北京:人民卫生出版社,2009:93-100. [13] 徐海侠,李春兰.艾滋病病人抗病毒治疗服药依从性与生存质量的相关性[J].中国艾滋病性病,2018,24(3):238-240. [14] 赵文宇. 艾滋病抗病毒治疗服药依从性及影响因素的研究[D].北京:中国疾病预防控制中心,2016. [15] 肖敏,黄金,王红红,等.HIV阳性男男性行为者抗病毒治疗依从性现状及影响因素研究[J].中国艾滋病性病,2019,25(1):48-51. [16] 曾琼,万彬,付莉,等.HIV阳性孕妇服药依从性的影响因素分析[J].护理研究,2018,32(2):259-261. [17] 邵英,刘晓宁,何克静,等.感染HIV孕产妇的社会支持现状及其与服药依从性的相关性[J].中国艾滋病性病,2020,26(11):1190-1192. [18] 张啟文,张金奖,谢学军,等.监狱服刑HIV感染者/AIDS患者抗病毒治疗服药依从性的影响因素[J].职业与健康,2019,35(19):2674-2677. [19] 高岩,崔元斌,龚一谦,等.HIV感染者/AIDS病人抗病毒治疗服药依从性管理相关循证指南的质量评价[J].护理研究,2020,34(3):414-419. [20] FORD N,MAYER K H.World health organization guidelines on post-exposure prophylaxis for hiv:Recommendations for a public health approach[J].Clin Infect Dis,2015,60(Suppl 3):S161-S164. [21] New York State Department of Health AIDS Institute.Clinical guidelines program[EB/OL].(2020-06)[2021-01-20].https://www.hivguidelines.org/pep-for-hiv-prevention/pep/. [22] Department of Health.HIV post-exposure prophylaxis:Guidance from the UK Chief Medical Officers’ Expert Advisory Group on AIDS[EB/OL].(2008-09-19)[2021-01-24].https://www.gov.uk/government/publications/eaga-guidance-on-hiv-post-exposure-prop-hylaxis. [23] 周宇,刘梦雅,高莉莉,等.基于信息化的服药依从性促进工具研究进展[J].护理研究,2020,34(23):4186-4190. [24] 胡美华,赵秀莉,赵艳春,等.医务人员感染性职业暴露后预防现状及改进探讨[J].中国护理管理,2020,20(2):250-253. [25] AMINDE L N,TAKAH N F,DZUDIE A,et al.Occupational post-exposure prophylaxis(PEP) against human immunodeficiency virus(HIV) infection in a health district in Cameroon:assessment of the knowledge and practices of nurses[J].PLoS One,2015,10(4):124416. [26] 田含章,易宜芳,李映兰.医护人员职业暴露后预防依从性及其影响因素研究进展[J].护理学杂志,2014,29(6):92-94. [27] MITZEL L D,VANABLE P A.Necessity and concerns beliefs and HIV medication adherence:A systematic review[J].J Behav Med,2020, 43(1):1-15. [28] KATZ I T,RYU A E,ONUEGBU A G,et al.Impact of HIV-related stigma on treatment adherence:Systematic review and meta-synthesis[J].J Int AIDS Soc,2013,16(3 Suppl 2):18640. [29] 吴锋耀,董文逸,韦彩云,等.艾滋病高发地区传染病医院医护人员职业卫生防护体系建设[J].中国护理管理,2018,18(2):150-153. [30] 解晨,孙珍,张静,等.综合医院医务人员职业接触防护体系建设与实践[J].中国护理管理,2015,15(9):1079-1082. |